Fibrillar β-amyloid 1-42 alters cytokine secretion, cholinergic signalling and neuronal differentiation

Journal of Cellular and Molecular Medicine

Volumn 18, Issue 9, 2014, Pages 1874-1888

  Malmsten, Linn ^a   Vijayaraghavan, Swetha ^a   Hovatta, Outi ^b   Marutle, Amelia ^a   Darreh Shori, Taher ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alzheimer's disease; Gliogenesis; Human embryonic stem cells; Human microglia; Inflammation; Neurogenesis; Neurospheres

Indexed keywords

ACETYLCHOLINE; AMYLOID; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); CHOLINE ACETYLTRANSFERASE; CHOLINESTERASE; CYTOKINE; PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; CELL LINE; HUMAN; IMMUNOLOGY; METABOLISM; MICROGLIA; MULTICELLULAR SPHEROID; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; PHYSIOLOGY; PRIMARY CELL CULTURE; SECRETION (PROCESS); SIGNAL TRANSDUCTION;

ACETYLCHOLINE; ALZHEIMER DISEASE; AMYLOID; AMYLOID BETA-PEPTIDES; BUTYRYLCHOLINESTERASE; CELL LINE; CHOLINE O-ACETYLTRANSFERASE; CYTOKINES; HUMANS; MICROGLIA; NEUROGENESIS; NEURONS; PEPTIDE FRAGMENTS; PRIMARY CELL CULTURE; SIGNAL TRANSDUCTION; SPHEROIDS, CELLULAR;

EID: 84908212696     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12343     Document Type: Article

References (55)

1. Streit WJ. Microglia and neuroprotection: implications for Alzheimer's disease. Brain Res Brain Res Rev. 2005; 48: 234-9.
2. Akiyama H, Barger S, Barnum S, et al. Inflammation and Alzheimer's disease. Neurobiol Aging. 2000; 21: 383-421.
3. Lambert MP, Barlow AK, Chromy BA, et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA. 1998; 95: 6448-53.
4. Shankar GM, Bloodgood BL, Townsend M, et al. Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci. 2007; 27: 2866-75.
5. Maezawa I, Zimin PI, Wulff H, et al. Amyloid-beta protein oligomer at low nanomolar concentrations activates microglia and induces microglial neurotoxicity. J Biol Chem. 2011; 286: 3693-706.
6. Garcao P, Oliveira CR, Agostinho P. Comparative study of microglia activation induced by amyloid-beta and prion peptides: role in neurodegeneration. J Neurosci Res. 2006; 84: 182-93.
7. Hjorth E, Frenkel D, Weiner H, et al. Effects of immunomodulatory substances on phagocytosis of abeta(1-42) by human microglia. Int J Alzheimers Dis. 2010; 2010: doi:10.4061/2010/798424.
8. Doi Y, Mizuno T, Maki Y, et al. Microglia activated with the toll-like receptor 9 ligand CpG attenuate oligomeric amyloid {beta} neurotoxicity in in vitro and in vivo models of Alzheimer's disease. Am J Pathol. 2009; 175: 2121-32.
9. Walton NM, Sutter BM, Laywell ED, et al. Microglia instruct subventricular zone neurogenesis. Glia. 2006; 54: 815-25.
10. Monje ML, Toda H, Palmer TD. Inflammatory blockade restores adult hippocampal neurogenesis. Science. 2003; 302: 1760-5.
11. Ekdahl CT, Claasen JH, Bonde S, et al. Inflammation is detrimental for neurogenesis in adult brain. Proc Natl Acad Sci USA. 2003; 100: 13632-7.
12. Czura CJ, Tracey KJ. Autonomic neural regulation of immunity. J Intern Med. 2005; 257: 156-66.
13. Darreh-Shori T, Forsberg A, Modiri N, et al. Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo. Neurobiol Aging. 2011; 32: 2320.e15-32.
14. Darreh-Shori T, Modiri N, Blennow K, et al. The apolipoprotein E epsilon4 allele plays pathological roles in AD through high protein expression and interaction with butyrylcholinesterase. Neurobiol Aging. 2011; 32: 1236-48.
15. Darreh-Shori T, Modiri N, Lahaut P, et al. Apolipoprotein E and Butyrylcholinesterase synergistically promote Ab peptides oligomerization. Alzheimer's & Dementia. 2009; 5: P225. Available at http://linkinghubelseviercom/retrieve/pii/S1552526009001915.
16. Darreh-Shori T, Modiri N, Nordberg A. ApoE and amyloid beta deflate the cholinergic neurotransmission by boosting the activity and stability of cholinesterases in the brain. Alzheimer's & Dementia. 2009; 5: P305. Available at http://linkinghubelseviercom/retrieve/pii/S1552526009005858
17. Vijayaraghavan S, Karami A, Aeinehband S, et al. Regulated extracellular choline acetyltransferase activity- the plausible missing link of the distant action of acetylcholine in the cholinergic anti-inflammatory pathway. PLoS ONE. 2013; 8: e65936.
18. Wicklund L, Leao RN, Stromberg AM, et al. Beta-amyloid 1-42 oligomers impair function of human embryonic stem cell-derived forebrain cholinergic neurons. PLoS ONE. 2010; 5: e15600.
19. Ginis I, Luo Y, Miura T, et al. Differences between human and mouse embryonic stem cells. Dev Biol. 2004; 269: 360-80.
20. Skottman H, Hovatta O. Culture conditions for human embryonic stem cells. Reproduction. 2006; 132: 691-8.
21. Nat R, Nilbratt M, Narkilahti S, et al. Neurogenic neuroepithelial and radial glial cells generated from six human embryonic stem cell lines in serum-free suspension and adherent cultures. Glia. 2007; 55: 385-99.
22. Romieu-Mourez R, Coutu DL, Galipeau J. The immune plasticity of mesenchymal stromal cells from mice and men: concordances and discrepancies. Front Biosci (Elite Ed). 2012; 4: 824-37.
23. Foldes G, Liu A, Badiger R, et al. Innate immunity in human embryonic stem cells: comparison with adult human endothelial cells. PLoS ONE. 2010; 5: e10501.
24. Johansson S, Price J, Modo M. Effect of inflammatory cytokines on major histocompatibility complex expression and differentiation of human neural stem/progenitor cells. Stem Cells. 2008; 26: 2444-54.
25. Kokaia Z, Martino G, Schwartz M, et al. Cross-talk between neural stem cells and immune cells: the key to better brain repair? Nat Neurosci. 2012; 15: 1078-87.
26. Liu J, Gotherstrom C, Forsberg M, et al. Human neural stem/progenitor cells derived from embryonic stem cells and fetal nervous system present differences in immunogenicity and immunomodulatory potentials in vitro. Stem Cell Research. 2013; 10: 325-37.
27. Inzunza J, Gertow K, Stromberg MA, et al. Derivation of human embryonic stem cell lines in serum replacement medium using postnatal human fibroblasts as feeder cells. Stem Cells. 2005; 23: 544-9.
28. Strom S, Inzunza J, Grinnemo KH, et al. Mechanical isolation of the inner cell mass is effective in derivation of new human embryonic stem cell lines. Hum Reprod. 2007; 22: 3051-8.
29. Strom S, Holm F, Bergstrom R, et al. Derivation of 30 human embryonic stem cell lines-improving the quality. In Vitro Cell Dev Biol Anim. 2010; 46: 337-44.
30. Nilbratt M, Porras O, Marutle A, et al. Neurotrophic factors promote cholinergic differentiation in human embryonic stem cell-derived neurons. J Cell Mol Med. 2010; 14: 1476-84.
31. Degerman Gunnarsson M, Lindau M, Wall A, et al. Pittsburgh compound-B and Alzheimer's disease biomarkers in CSF, plasma and urine: an exploratory study. Dement Geriatr Cogn Disord. 2010; 29: 204-12.
32. Darreh-Shori T, Brimijoin S, Kadir A, et al. Differential CSF butyrylcholinesterase levels in Alzheimer's disease patients with the ApoE epsilon4 allele, in relation to cognitive function and cerebral glucose metabolism. Neurobiol Dis. 2006; 24: 326-33.
33. Darreh-Shori T, Meurling L, Pettersson T, et al. Changes in the activity and protein levels of CSF acetylcholinesterases in relation to cognitive function of patients with mild Alzheimer's disease following chronic donepezil treatment. J Neural Transm. 2006; 113: 1791-801.
34. Darreh-Shori T, Vijayaraghavan S, Aeinehband S, et al. Functional variability in butyrylcholinesterase activity regulates intrathecal cytokine and astroglial biomarker profiles in patients with Alzheimer's disease. Neurobiol Aging. 2013; 34: 2465-81.
35. Heneka MT, O'Banion MK, Terwel D, et al. Neuroinflammatory processes in Alzheimer's disease. J Neural Transm. 2010; 117: 919-47.
36. Zhao ML, Liu JS, He D, et al. Inducible nitric oxide synthase expression is selectively induced in astrocytes isolated from adult human brain. Brain Res. 1998; 813: 402-5.
37. Tracey KJ. The inflammatory reflex. Nature. 2002; 420: 853-9.
38. Darreh-Shori T, Siawesh M, Mousavi M, et al. Apolipoprotein epsilon4 modulates phenotype of butyrylcholinesterase in CSF of patients with Alzheimer's disease. J Alzheimers Dis. 2012; 28: 443-58.
39. Vallieres L, Campbell IL, Gage FH, et al. Reduced hippocampal neurogenesis in adult transgenic mice with chronic astrocytic production of interleukin-6. J Neurosci. 2002; 22: 486-92.
40. Bowen KK, Dempsey RJ, Vemuganti R. Adult interleukin-6 knockout mice show compromised neurogenesis. NeuroReport. 2011; 22: 126-30.
41. Draberova E, Del Valle L, Gordon J, et al. Class III beta-tubulin is constitutively coexpressed with glial fibrillary acidic protein and nestin in midgestational human fetal astrocytes: implications for phenotypic identity. J Neuropathol Exp Neurol. 2008; 67: 341-54.
42. Carter SF, Scholl M, Almkvist O, et al. Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG. J Nucl Med. 2012; 53: 37-46.
43. Matus A. Microtubule-associated proteins and the determination of neuronal form. J Physiol. 1990; 84: 134-7.
44. Bernardino L, Agasse F, Silva B, et al. Tumor necrosis factor-alpha modulates survival, proliferation, and neuronal differentiation in neonatal subventricular zone cell cultures. Stem Cells. 2008; 26: 2361-71.
45. Cacci E, Ajmone-Cat MA, Anelli T, et al. In vitro neuronal and glial differentiation from embryonic or adult neural precursor cells are differently affected by chronic or acute activation of microglia. Glia. 2008; 56: 412-25.
46. Spulber S, Oprica M, Bartfai T, et al. Blunted neurogenesis and gliosis due to transgenic overexpression of human soluble IL-1ra in the mouse. Eur J Neurosci. 2008; 27: 549-58.
47. Tracey KJ. Reflex control of immunity. Nat Rev Immunol. 2009; 9: 418-28.
48. Tyagi E, Agrawal R, Nath C, et al. Inhibitory role of cholinergic system mediated via alpha7 nicotinic acetylcholine receptor in LPS-induced neuro-inflammation. Innate Immun. 2010; 16: 3-13.
49. Shytle RD, Mori T, Townsend K, et al. Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors. J Neurochem. 2004; 89: 337-43.
50. Landgraf D, Barth M, Layer PG, et al. Acetylcholine as a possible signaling molecule in embryonic stem cells: studies on survival, proliferation and death. Chem Biol Interact. 2010; 187: 115-9.
51. Bao F, Wicklund L, Lacor PN, et al. Different beta-amyloid oligomer assemblies in Alzheimer brains correlate with age of disease onset and impaired cholinergic activity. Neurobiol Aging. 2012; 33: 825.e1-13.
52. Kadir A, Marutle A, Gonzalez D, et al. Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease. Brain. 2011; 134: 301-17.
53. Geula C, Darvesh S. Butyrylcholinesterase, cholinergic neurotransmission and the pathology of Alzheimer's disease. Drugs Today (Barc). 2004; 40: 711-21.
54. Boche D, Perry VH, Nicoll JA. Review: activation patterns of microglia and their identification in the human brain. Neuropathol Appl Neurobiol. 2013; 39: 3-18.
55. Streit WJ. Microglia and Alzheimer's disease pathogenesis. J Neurosci Res. 2004; 77: 1-8.